HER2 Breast Cancer Tweetorial 3: HER2 Intratumoral Heterogeneity

Activity Overview

Target Audience

This activity has been designed to meet the educational needs of pathologists, laboratory professionals, and other members of the cancer care team.

Activity Agenda

• Background
• HER2-low breast cancer
• HER2 intratumoral heterogeneity
• Wrap up

The activity offers 0.5 CME/CMLE credit.

Upon completion of this activity, you will be able to:

• Appropriately conduct IHC and ISH testing, classification, and reporting in routine and complex breast cancer cases across the HER2 spectrum in accordance with guidelines
• Describe the science and emerging evidence around the diagnosis, testing, and treatment of patients with HER2-low breast cancer
• Update laboratory processes and procedures
• Outline ways to improve communication and coordination among pathologists, oncologists, and other members of the cancer care team when discussing HER2 test results in patients with breast cancer

Dr. Kim has no relevant financial relationships to disclose

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

The ASCP designates this enduring internet activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ASCP designates this enduring internet activity for a maximum of 0.5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.